Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
City of Hope Medical Center
City of Hope Medical Center
MacroGenics
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Blueprint Medicines Corporation
Allakos Inc.